290 related articles for article (PubMed ID: 33960076)
1. Very late onset neuromyelitis optica spectrum disorders.
Nakahara K; Nakane S; Nagaishi A; Narita T; Matsuo H; Ando Y
Eur J Neurol; 2021 Aug; 28(8):2574-2581. PubMed ID: 33960076
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder.
Cai LJ; Zhang Q; Zhang Y; Chen HX; Shi ZY; Du Q; Zhou HY
Mult Scler Relat Disord; 2020 Nov; 46():102515. PubMed ID: 33032051
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.
Min W; Zhang L; Wang S; Xue M; Guo C; Zhu M
Mult Scler Relat Disord; 2023 Feb; 70():104517. PubMed ID: 36708681
[TBL] [Abstract][Full Text] [Related]
5. Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder.
Hu Y; Sun Q; Yi F; Yao L; Tian Y; Tang H; Luo M; Xie N; Wang Z; Liao X; Zhou L; Xu H; Zhou Y
Front Immunol; 2022; 13():1056944. PubMed ID: 36569880
[TBL] [Abstract][Full Text] [Related]
6. Age at onset predicts outcome in aquaporin-4-IgG positive neuromyelitis optica spectrum disorder from a United Kingdom population.
Papathanasiou A; Tanasescu R; Tench CR; Rocha MF; Bose S; Constantinescu CS; Jacob S
J Neurol Sci; 2021 Dec; 431():120039. PubMed ID: 34715481
[TBL] [Abstract][Full Text] [Related]
7. Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort.
Castro-Suarez S; Guevara-Silva E; Osorio-Marcatinco V; Alvarez-Toledo K; Meza-Vega M; Caparó-Zamalloa C
Mult Scler Relat Disord; 2022 Aug; 64():103919. PubMed ID: 35691236
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSD.
Paolilo RB; Rimkus CM; da Paz JA; Apostolos-Pereira SL; Callegaro D; Sato DK
Mult Scler Relat Disord; 2022 Dec; 68():104215. PubMed ID: 36257150
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Early- and Late-Onset NMOSD-Related Optic Neuritis in Thai Patients: Clinical Characteristics and Long-Term Visual Outcomes.
Thongmee W; Narongkhananukul C; Padungkiatsagul T; Jindahra P; Vanikieti K
Clin Ophthalmol; 2021; 15():419-429. PubMed ID: 33574650
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort.
Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Ariel B; Castillo MC; Cristiano E; Diégues Serva GB; Dos Santos AC; Finkelsteyn AM; López PA; Patrucco L; Molina O; Pettinicchi JP; Toneguzzo V; Caride A; Rojas JI
J Neurol; 2020 May; 267(5):1260-1268. PubMed ID: 31932911
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
12. Late-onset neuromyelitis optica spectrum disorder: A case series from Iran.
Ghadiri F; Eskandarieh S; Sahraian MA; Azimi A; Moghadasi AN
Rev Neurol (Paris); 2022 Mar; 178(3):249-252. PubMed ID: 34776261
[TBL] [Abstract][Full Text] [Related]
13. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.
Hu H; You X; Ye J
Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441
[TBL] [Abstract][Full Text] [Related]
14. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients.
Lana-Peixoto MA; Talim NC; Callegaro D; Marques VD; Damasceno A; Becker J; Gonçalves MVM; Sato H;
Mult Scler Relat Disord; 2023 Jul; 75():104730. PubMed ID: 37156036
[TBL] [Abstract][Full Text] [Related]
16. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
[TBL] [Abstract][Full Text] [Related]
17. Late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies.
Wang L; Tan H; Huang W; Chang X; ZhangBao J; Zhou L; Lu C; Wang M; Lu J; Zhao C; Quan C
Eur J Neurol; 2022 Apr; 29(4):1128-1135. PubMed ID: 34967093
[TBL] [Abstract][Full Text] [Related]
18. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
Mealy MA; Mossburg SE; Kim SH; Messina S; Borisow N; Lopez-Gonzalez R; Ospina JP; Scheel M; Yeshokumar AK; Awad A; Leite MI; Arango JJ; Paul F; Palace J; Kim HJ; Levy M
Mult Scler Relat Disord; 2019 Feb; 28():64-68. PubMed ID: 30554040
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study.
Villa AM; Manin A; Seimandi C; Finkelsteyn AM; Ramos G; Tenembaum S
Mult Scler Relat Disord; 2023 Nov; 79():105018. PubMed ID: 37806234
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis.
Kim SH; Hyun JW; Joung A; Lee SH; Kim HJ
PLoS One; 2016; 11(12):e0167783. PubMed ID: 27936193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
